1 |
Agrippal s1 (influenza vaccination) |
- |
- |
- |
- |
046 [1] 46 💬 |
2 |
Belimumab plus early vaccination |
Belimumab |
[1] D03068 D03068 💬 |
TNFSF13B [1] TNFSF13B 💬 |
Cytokine-cytokine receptor interaction [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis |
049 [1] 49 💬 |
3 |
Belimumab plus late vaccination |
Belimumab |
[1] D03068 D03068 💬 |
TNFSF13B [1] TNFSF13B 💬 |
Cytokine-cytokine receptor interaction [4] Cytokine-cytokine receptor interaction, Intestinal immune network for IgA production, NF-kappa B signaling pathway, Rheumatoid arthritis |
049 [1] 49 💬 |
4 |
Human papillomavirus vaccination (gardasil) |
- |
- |
- |
- |
049 [1] 49 💬 |
5 |
Influenza vaccination |
- |
- |
- |
- |
299 [1] 299 💬 |
6 |
Multiple (4 autologous subcutaneous t cell vaccinations with t cell lines reactive to nine myelin peptides) |
- |
- |
- |
- |
013 [1] 13 💬 |
7 |
Prevenar vaccination |
- |
- |
- |
- |
046 [1] 46 💬 |
8 |
T cell vaccination |
- |
- |
- |
- |
013 [1] 13 💬 |
9 |
T-cell vaccination |
- |
- |
- |
- |
013 [1] 13 💬 |
10 |
Vaccination |
- |
- |
- |
- |
049 [1] 49 💬 |
11 |
Vaccination against tbe |
- |
- |
- |
- |
046 [1] 46 💬 |
12 |
Vaccination with vaccine against hepatitis a and b |
- |
- |
- |
- |
299 [1] 299 💬 |